September 23, 2021
Article
This month's featured products include an infants' pain and fever reducer, daily supplements for nerve care and pain, and more.
The COVID-19 booster doses are to be administered at least 6 months after completion of the primary 2-dose series and are the same formulation and dosage strength as the original doses.
Remdesivir demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19-related hospitalization or all-cause death by day 28.
Ten quiz questions to assess your knowledge on common symptoms and treatments for genital herpes.
Crizanlizumab is a humanized IgG2 kappa monoclonal antibody that binds to P-selectin and blocks interactions with its ligands.
DEA seizure of large-scale narcotics points to potential drug diversion in supply chain.
September 22, 2021
Ideas for potential new services are often plentiful, but these ideas must be carefully evaluated in order to select the right one and see it to fruition.
Video
In part 2 of their discussion on COVID-19 vaccine mandates, experts Ned Milenkovich, PharmD, and Ron Lanton III, Esq., discussed how provider status could impact potential legal issues around COVID-19 vaccine mandates.
Doctors and pharmacists discuss OTC and prescription treatment options and use during webcast.
In clinical trials, the majority of patients with atopic dermatitis treated with ruxolitinib had clear or almost clear skin.
